Delaware Overrides Marijuana Zoning Veto: What the Local-Control Fight Could Mean for Access
Delaware marijuana zoning veto override: Delaware lawmakers completed a July 1, 2026 veto override on SB 75, limiting county restrictions on marijuana establishments. The law affects certain compassion-center retail conversions, building-permit disputes,…
SAMHSA’s 2026 Clinical Guidance for Physicians and Patients on Cannabis Use Disorder
SAMHSA released a formal 2026 advisory instructing primary care physicians to evaluate cannabis use based on clinical signs of harm, not simply patient use. Dr. Caplan breaks down what this federal guidance actually says, where current diagnostic tools…
What the 2026 DOJ Rescheduling Order Means in Practice
On April 23, 2026, the U.S. DOJ moved state-licensed medical cannabis to Schedule III, the first federal acknowledgment of accepted medical value in 55 years. Dr. Caplan breaks down what actually changed for patients, physicians, and the research…
Cannabis Policy Shift Explained – Per NY Times
The cannabis rescheduling Trump policy is reshaping industry economics. Tax relief and investment may increase. But clinical care and evidence remain largely unchanged.
Should marijuana access be expanded? On April 23, 2026, the Trump administration … – Facebook
✦ New CED Clinical Relevance #55 Clinical Context Background information relevant to the evolving cannabis medicine landscape. PolicyResearchMedical MarijuanaMental Health Clinical Summary The Trump administration’s April 2026 policy…
Israel and Lebanon extend ceasefire. And, Trump eases medical marijuana rules – NPR
✦ New CED Clinical Relevance #76Notable Clinical Interest Emerging findings or policy developments worth monitoring closely. ⚒ Cannabis News | CED Clinic PolicyMedical MarijuanaFederal…
What to know about Trump’s reclassification of state-licensed medical marijuana – The Hill
Trump medical marijuana reclassification could transform clinical practice by removing Schedule I barriers. This change allows physicians to prescribe cannabis and expands research opportunities. Patients and providers should stay informed about these…
Trump Administration Moves to Ease Medical Marijuana Restrictions
The Trump administration medical marijuana policy is evolving with eased federal restrictions. These changes could improve patient access and research opportunities. Clinicians should monitor how this policy update affects clinical practice and…
Trump Administration Live Updates: Justice Dept. Loosens Medical Marijuana Restrictions
The Justice Department eases restrictions on some marijuana products, signaling a shift in federal medical cannabis enforcement. This change may improve patient access and reduce legal liability for clinicians. It represents a notable update in cannabis…
Tennessee Lawmakers Vote To Block Potential State Medical Marijuana Legalization After Federal Rescheduling
Tennessee medical marijuana legislation has recently blocked potential legalization despite federal rescheduling efforts. This state-level prohibition limits patient access to cannabis therapies. Clinicians must navigate these restrictions while staying…